Starting with the elderly and frontline workers, Britain began mass vaccinating its population on Tuesday
The company's Indian arm has sought emergency use authorisation (EUA) for the Pfizer/BioNTech vaccine against Covid-19 in the country from the Indian drug regulator.
Having achieved the first goal of seeing whether the vaccines work, we can be more ambitious and design studies to assess whether and how much they reduce transmission, says Kang
Bharat Biotech, Serum Institute of India and Pfizer have applied to the Drugs Controller General of India seeking emergency use authorisation for their Covid-19 vaccine candidates
ICMR Director General Balram Bhargava said that in the case of temporary licensure or emergency use, the regulator had to be satisfied with the risk-benefit ratio.
The Food and Drug Administration posted its analysis online even as across the Atlantic, Britain on Tuesday began vaccinating its oldest citizens with the Pfizer-BioNTech shots
An 87-year-old Indian-origin man from England will become one of the first people in the world to get a vaccine against Covid-19 when he receives his Pfizer-BioNTech
Mukesh Ambani says Jio will pioneer the 5G revolution in India and Nirmala Sitharaman says she isn't worried about budget deficit for now. More top headlines of the day
Margaret Keenan, a 90-year-old grandmother from Britain, has become the first person in the world to receive the Pfizer Covid-19 vaccine outside of a trial following its rapid clinical approval
In this podcast, we will talk about the Covid Vaccine scenario, in which we will discuss trial results, efficacy among other things
The UK is set to begin administering doses from Pfizer and German partner BioNTech SE on Tuesday, making it the first Western country to receive a vaccine
As the vaccines arrive, how are they going to be distributed? Can individuals or private parties import them freely? What will the cost be? Will the disease progress the way it has?
Prime Minister Justin Trudeau said Monday Canada will get up to 250,000 doses of the vaccine developed by American drugmaker Pfizer and Germany's BioNTech before the end of December.
Vaccine by Pfizer and BioNTech could be in use in the US by Friday if the FDA approves emergency use
After the Indian arm of US pharmaceutical giant Pfizer, the Serum Institute of India has applied to the Drugs Controller General of India (DCGI) seeking emergency use authorisation
Serum Institute is making AstraZeneca's Covid-19 vaccine in India and has applied for emergency use authorisation.
The company has developed detailed logistical plans and tools to support effective vaccine transport, storage, and temperature monitoring.
US, China also set to start process of inoculating their citizens from this week
The ultra-cold chain requirement of Pfizer's vaccine, unlike most other vaccines, makes it a challenge for most countries including India to store and transport
Supply chains have been tested in ways they never have been before and, yes, there have been pileups, shortages and other snafus